Sponsored
released by
Merck
06.09.21
Risk Management
FDA Watch
-
Parenterals | Risk Management
Drug Shortages Threaten Patients: How Pharma Can Build Supply Chain Resilience
Preventing drug shortages with supply chain risk assessment.Online Exclusives Charles Sternberg, Associate Editor 04.19.24
-
Breaking News | Industry News | Risk Management
Ginkgo Acquires Key Assets of Reverie Labs
Strengthens its AI/ML-driven discovery services offering and accelerates its work to build next-gen biological foundation models.02.28.24
-
APIs | Breaking News | Collaborations & Alliances | Excipients | Industry News | QA/QC | Risk Management
Valisure, DoD Conduct Pharmaceutical Quality Risk Assessment Study
Partnership will generate objective drug quality data through independent sourcing and testing.08.14.23
-
APIs | Drug Development | Risk Management
How Respiratory Protection Upgrades Safeguard Pharma Manufacturing
The use of PAPRs and SARs is increasing due to potential drug potency exposures during manufacturing and greater awareness of respiratory technology advances.12.22.22
-
Biologics, Proteins, Vaccines | Clinical Trials | Drug Development | Inspections | Process Validation | Risk Management
Establishing Commercial Manufacturing Services for Antibody-Drug Conjugates
Learn how to properly structure your development work, perform a thorough process risk assessment and prepare for pre-approval inspection audit.
-
APIs | Drug Development | Risk Management
Small-Molecule Drug Development: Advantages of an Integrated, Phase-Based Approach
Small-molecule drug development has become more complex and challenging, leading to greater reliance on CDMOs.Sarah Bethune, Cambrex 09.09.20
-
Analytical Services | Breaking News | Risk Management
CluePoints Tech Benefits Clinical Studies Affected by COVID-19
Its COVID-19 risk assessment package and Data Surveillance solution is being utilized in over 200 ongoing studies.Contact Pharma Staff 05.07.20
-
Analytical Services | APIs | Capsules | Chemistry | Clinical Trial Materials | Drug Delivery | Drug Development | Drug Discovery | Excipients | Fill/Finish | Formulation Development | Inspections | Microbiology | Parenterals | Process Development | Process Validation | Regulatory Affairs | Risk Management | Supply Chain | Validation | Vials
-
Bio News | cGMP Manufacture | Industry News | Regulatory Affairs | Risk Management
Stellar Announces Positive Third-Party Trial Results
The company's KLH manufacturing methods have achieved robust viral clearance05.29.18
-
Bio News | cGMP Manufacture | Drug Delivery | Facilities | Industry News | Laboratory Testing | Risk Management
Quay Expands Specialist Isolation Suites
The suites are to support the development of potent drugs in a protective environment03.06.18
-
Breaking News | cGMP Manufacture | Drug Delivery | Industry News | Risk Management | Supply Chain
Pharmapack 2018 Announces Winners
The six winners were chosen across two categories: Exhibitor Innovation and Health ProductVideos02.15.18
-
Breaking News | Industry News | QA/QC | Risk Management
Sanofi to Transform its Contracting Foundation
Selects Icertis’ digital platform for cloud management09.01.17
-
Drug Development | Risk Management
Mitigating Regulatory Risk for a Global Product Launch
Addressing the critical regulatory challenges life science companies face in today's marketOnline Exclusives Kristin Brooks, Contract Pharma 11.22.16
-
APIs | Clinical Trials | Drug Development | Information Technology | Regulatory Affairs | Risk Management
News Highlights from the 2016 Annual DIA Meeting
Comprehend Launches Clinical Intelligence Suite, Quintiles Launches CGM Service Offering, and more...Online Exclusives07.06.16
-
Drug Development | Excipients | Lyophilization | Risk Management
Clinical Manufacturing On Time and Within Budget
...David Brett, Vetter Pharma International GmbH 06.02.16
-
Biosimilars | Risk Management
India Revises Biosimilars Guidelines
Stricter quality, safety norms on cardsS. Harachand, Contributing Editor 05.05.16
-
APIs | Cleaning Validation | Clinical Trials | Drug Development | Drug Discovery | Risk Management | Toxicology | Validation
Setting Health-Based Exposure Limits to Support Pharmaceutical Development and Manufacturing
Health-based exposure limits are needed to support risk assessmentsB.D. Naumann, P.J. Nigro, U. Bruen, L. Parola, D. Cragin and A. Schatz, Merck & Co., Inc. and Ashland, Inc. 05.05.16
-
Drug Delivery | Drug Development | Excipients | Process Development | Process Validation | Risk Management | Validation
Process Development Trends
An approach to process development of pMDIs using cold fill and pressure fill technologySteve Haswell, 3M Drug Delivery Systems 05.05.16
-
Risk Management | Supply Chain | Validation
Pharma IT Trends
The challenge of implementing MES technology with increased regulationChristian Fortunel, LZ Lifescience 05.05.16
-
Risk Management
Should We Call It Risk or Relevance?
What is the difference and what does it mean?Ben Locwin, Contributing Editor 04.05.16
